Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Adams

Showing results (111-120 of 207) with videos related to

Pageof 21
Sort By:
Stem Cell Research|October 26, 2024
Generation and characterization of two iPSC lines derived from subjects with Free Sialic Acid Storage Disorder (FSASD)Marya S Sabir, Petcharat Leoyklang, Mary E Hackbarth, et al.
The Biochemical Journal|March 4, 2010
Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERKXiang Li, Suryakiran Vadrevu, Allan Dunlop, et al.
Molecular Genetics and Metabolism|April 11, 2025
RNA sequencing driven diagnosis expands the phenotypic spectrum of NBAS deficiencySarah Silverstein, Thomas Cassini, Jiayu Fu, et al.
Human Mutation|February 1, 2012
Analysis of DNA sequence variants detected by high-throughput sequencingDavid R Adams, Murat Sincan, Karin Fuentes Fajardo, et al.
Molecular Pharmacology|April 19, 2011
Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulatorNicola J Smith, Richard J Ward, Leigh A Stoddart, et al.
The Biochemical Journal|March 18, 2004
Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase geneLee Ann Johnston, Suat Erdogan, York Fong Cheung, et al.
The Biochemical Journal|February 10, 2007
Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arraysGeorge S Baillie, David R Adams, Narinder Bhari, et al.
Cellular Signalling|September 29, 2007
1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1K John Smith, George S Baillie, Eva I Hyde, et al.
American Journal of Medical Genetics. Part A|October 30, 2016
Sudden infant death "syndrome"-Insights and future directions from a Utah population database analysisErik D Christensen, Justin Berger, Mouied M Alashari, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2019
A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblingsFangning Gu, Anchi Wu, M Grace Gordon, et al.
Pageof 21

Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
Stem Cell Research|October 26, 2024
Generation and characterization of two iPSC lines derived from subjects with Free Sialic Acid Storage Disorder (FSASD)Marya S Sabir, Petcharat Leoyklang, Mary E Hackbarth, et al.
The Biochemical Journal|March 4, 2010
Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERKXiang Li, Suryakiran Vadrevu, Allan Dunlop, et al.
Molecular Genetics and Metabolism|April 11, 2025
RNA sequencing driven diagnosis expands the phenotypic spectrum of NBAS deficiencySarah Silverstein, Thomas Cassini, Jiayu Fu, et al.
Human Mutation|February 1, 2012
Analysis of DNA sequence variants detected by high-throughput sequencingDavid R Adams, Murat Sincan, Karin Fuentes Fajardo, et al.
Molecular Pharmacology|April 19, 2011
Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulatorNicola J Smith, Richard J Ward, Leigh A Stoddart, et al.
The Biochemical Journal|March 18, 2004
Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase geneLee Ann Johnston, Suat Erdogan, York Fong Cheung, et al.
The Biochemical Journal|February 10, 2007
Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arraysGeorge S Baillie, David R Adams, Narinder Bhari, et al.
Cellular Signalling|September 29, 2007
1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1K John Smith, George S Baillie, Eva I Hyde, et al.
American Journal of Medical Genetics. Part A|October 30, 2016
Sudden infant death "syndrome"-Insights and future directions from a Utah population database analysisErik D Christensen, Justin Berger, Mouied M Alashari, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2019
A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblingsFangning Gu, Anchi Wu, M Grace Gordon, et al.
Pageof 21